Virus-based nanocarriers for drug delivery.
暂无分享,去创建一个
[1] J. Kaper. ALKALINE DEGRADATION OF TURNIP YELLOW MOSAIC VIRUS. I. THE CONTROLLED FORMATION OF EMPTY PROTEIN SHELLS. , 1964, Biochemistry.
[2] Effect of freezing and thawing on the structure of turnip yellow mosaic virus. , 2005, European journal of biochemistry.
[3] I. K. Robinson,et al. Structure of the expanded state of tomato bushy stunt virus , 1982, Nature.
[4] P. Sorger,et al. Structure and assembly of turnip crinkle virus. II. Mechanism of reassembly in vitro. , 1986, Journal of molecular biology.
[5] Carl O. Pabo,et al. Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.
[6] Lars Liljas,et al. The three-dimensional structure of the bacterial virus MS2 , 1990, Nature.
[7] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[8] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[9] A. Bacher,et al. The lumazine synthase-riboflavin synthase complex of Bacillus subtilis. Crystallization of reconstituted icosahedral beta-subunit capsids. , 1990, The Journal of biological chemistry.
[10] Stephen Mann,et al. Synthesis of inorganic nanophase materials in supramolecular protein cages , 1991, Nature.
[11] L. Liljas,et al. Crystallization and preliminary X-ray diffraction studies of the bacteriophage Qbeta. , 1994, Acta crystallographica. Section D, Biological crystallography.
[12] J Barsoum,et al. Tat-mediated delivery of heterologous proteins into cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[13] John E. Johnson,et al. Structures of the native and swollen forms of cowpea chlorotic mottle virus determined by X-ray crystallography and cryo-electron microscopy. , 1995, Structure.
[14] G J Strous,et al. Endocytosis of GPI-linked membrane folate receptor-alpha , 1996, The Journal of cell biology.
[15] P. Pumpens,et al. RNA Phage Qβ Coat Protein as a Carrier for Foreign Epitopes , 1996 .
[16] D. Brough,et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins , 1997, Journal of virology.
[17] P. Pumpens,et al. Mosaic Qβ coats as a new presentation model , 1998 .
[18] R. Langer,et al. Drug delivery and targeting. , 1998, Nature.
[19] Sung-Hou Kim,et al. Crystal structure of a small heat-shock protein , 1998, Nature.
[20] Trevor Douglas,et al. Host–guest encapsulation of materials by assembled virus protein cages , 1998, Nature.
[21] J. V. van Lier,et al. Metal complexes as photo- and radiosensitizers. , 1999, Chemical reviews.
[22] M. Perricaudet,et al. RGD Inclusion in the Hexon Monomer Provides Adenovirus Type 5-Based Vectors with a Fiber Knob-Independent Pathway for Infection , 1999, Journal of Virology.
[23] H. M. Petrassi,et al. Characterization of the structure and function of W --> F WW domain variants: identification of a natively unfolded protein that folds upon ligand binding. , 1999, Biochemistry.
[24] H. Petry,et al. Packaging of small molecules into VP1-virus-like particles of the human polyomavirus JC virus. , 2000, Journal of virological methods.
[25] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[26] K. Kataoka,et al. Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.
[27] R A Milligan,et al. Automated identification of filaments in cryoelectron microscopy images. , 2001, Journal of structural biology.
[28] B. Cargile,et al. Identification of bacteriophage MS2 coat protein from E. coli lysates via ion trap collisional activation of intact protein ions. , 2001, Analytical chemistry.
[29] G. Böhm,et al. Binding of external ligands onto an engineered virus capsid. , 2001, Protein engineering.
[30] R. Ho,et al. Trends and developments in liposome drug delivery systems. , 2001, Journal of pharmaceutical sciences.
[31] J. Witz,et al. The formation of empty shells upon pressure induced decapsidation of turnip yellow mosaic virus , 2001, Archives of Virology.
[32] M. Young,et al. Protein Engineering of a Viral Cage for Constrained Nanomaterials Synthesis , 2002 .
[33] Philip S Low,et al. Folate-mediated delivery of macromolecular anticancer therapeutic agents. , 2002, Advanced drug delivery reviews.
[34] M. Young,et al. Chemical modification of a viral cage for multivalent presentation. , 2002, Chemical communications.
[35] L. Canham,et al. Use of Microcontact Printing Methods to Direct Pattern Formation of Calcified Mesoporous Silicon , 2002 .
[36] R. Jain,et al. Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.
[37] D. Peabody. A Viral Platform for Chemical Modification and Multivalent Display , 2003, Journal of nanobiotechnology.
[38] G. Lomonossoff,et al. Cowpea mosaic virus-based chimaeras. Effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses. , 2003, Virology.
[39] S. Klußmann,et al. Spiegelmers: Biostable Aptamers , 2003, Chembiochem : a European journal of chemical biology.
[40] John E. Johnson,et al. Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus. , 2003 .
[41] R. Garcea,et al. Virus-like particles as vaccines and vessels for the delivery of small molecules. , 2004, Current opinion in biotechnology.
[42] Jacob M Hooker,et al. Interior surface modification of bacteriophage MS2. , 2004, Journal of the American Chemical Society.
[43] John E. Johnson,et al. Heterologous expression of the modified coat protein of Cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function. , 2004, The Journal of general virology.
[44] P. Heegaard,et al. Dendrimers in drug research. , 2004, Chemical Society reviews.
[45] Wadih Arap,et al. Design and validation of a bifunctional ligand display system for receptor targeting. , 2004, Chemistry & biology.
[46] M. Young,et al. Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture. , 2005, Chemical communications.
[47] M. Finn,et al. Accelerated bioorthogonal conjugation: a practical method for the ligation of diverse functional molecules to a polyvalent virus scaffold. , 2005, Bioconjugate chemistry.
[48] M. Finn,et al. Virus-glycopolymer conjugates by copper(I) catalysis of atom transfer radical polymerization and azide-alkyne cycloaddition. , 2005, Chemical communications.
[49] M. Francis,et al. Dual-surface modification of the tobacco mosaic virus. , 2005, Journal of the American Chemical Society.
[50] Jing C. Zhou,et al. Engineering of vault nanocapsules with enzymatic and fluorescent properties. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[51] Peter G Stockley,et al. Engineering thermal stability in RNA phage capsids via disulphide bonds. , 2005, Journal of nanoscience and nanotechnology.
[52] P. Singh,et al. Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. , 2006, Advanced drug delivery reviews.
[53] Marianne Manchester,et al. Canine parvovirus-like particles, a novel nanomaterial for tumor targeting , 2006, Journal of nanobiotechnology.
[54] F. Tama,et al. Removal of Divalent Cations Induces Structural Transitions in Red Clover Necrotic Mosaic Virus, Revealing a Potential Mechanism for RNA Release , 2006, Journal of Virology.
[55] Andries Zijlstra,et al. Viral nanoparticles as tools for intravital vascular imaging , 2006, Nature Medicine.
[56] Sek-Man Wong,et al. In vitro-reassembled plant virus-like particles for loading of polyacids. , 2006, The Journal of general virology.
[57] V. Rotello,et al. Quantum dot encapsulation in viral capsids. , 2006, Nano letters.
[58] Gustavo Helguera,et al. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. , 2006, Clinical immunology.
[59] John E. Johnson,et al. The role of subunit hinges and molecular "switches" in the control of viral capsid polymorphism. , 2006, Journal of structural biology.
[60] T. Daniels,et al. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. , 2006, Clinical immunology.
[61] Marianne Manchester,et al. Viruses and their uses in nanotechnology , 2006 .
[62] Trevor Douglas,et al. Viruses: Making Friends with Old Foes , 2006, Science.
[63] Scott C. Brown,et al. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[64] Y. Chiang,et al. Virus-Enabled Synthesis and Assembly of Nanowires for Lithium Ion Battery Electrodes , 2006, Science.
[65] Jacob M Hooker,et al. Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system. , 2007, Bioconjugate chemistry.
[66] A. Belcher,et al. Weaving Genetically Engineered Functionality into Mechanically Robust Virus Fibers , 2007 .
[67] Duane E. Prasuhn,et al. Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[68] Sek-Man Wong,et al. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. , 2007, Bioconjugate chemistry.
[69] Nico A J M Sommerdijk,et al. A virus-based single-enzyme nanoreactor. , 2007, Nature nanotechnology.
[70] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[71] D. Clark,et al. Solubilization and stabilization of bacteriophage MS2 in organic solvents , 2007, Biotechnology and bioengineering.
[72] Michael L Klein,et al. Emerging Applications of Polymersomes in Delivery: from Molecular Dynamics to Shrinkage of Tumors. , 2007, Progress in polymer science.
[73] R. Nolte,et al. Monodisperse polymer-virus hybrid nanoparticles. , 2007, Organic & biomolecular chemistry.
[74] M. Young,et al. Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[75] M. Young,et al. Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo , 2007, International journal of nanomedicine.
[76] Trevor Douglas,et al. Biological Containers: Protein Cages as Multifunctional Nanoplatforms , 2007 .
[77] V. Rotello,et al. Core-like particles of an enveloped animal virus can self-assemble efficiently on artificial templates. , 2007, Nano letters.
[78] Marianne Manchester,et al. Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. , 2007, Chemistry & biology.
[79] S. Franzen,et al. Encapsidation of nanoparticles by red clover necrotic mosaic virus. , 2007, Journal of the American Chemical Society.
[80] T. Dreher,et al. Turnip yellow mosaic virus as a chemoaddressable bionanoparticle. , 2007, Bioconjugate chemistry.
[81] Signal ampflication using nanoplatform cluster formation , 2008 .
[82] Duane E. Prasuhn,et al. Plasma clearance of bacteriophage Qbeta particles as a function of surface charge. , 2008, Journal of the American Chemical Society.
[83] Yu-Ying He,et al. Pristine (C60) and hydroxylated [C60(OH)24] fullerene phototoxicity towards HaCaT keratinocytes: type I vs type II mechanisms. , 2008, Chemical research in toxicology.
[84] H. Horinouchi,et al. Structure, photophysical property, and cytotoxicity of human serum albumin complexed with tris(dicarboxymethylene)[60]fullerene. , 2008, Bioconjugate chemistry.
[85] M. Francis,et al. Oxidative coupling of peptides to a virus capsid containing unnatural amino acids. , 2008, Chemical communications.
[86] P. Tsao,et al. A human ferritin iron oxide nano‐composite magnetic resonance contrast agent , 2008, Magnetic resonance in medicine.
[87] Chris S. Rae,et al. Interaction of Cowpea Mosaic Virus (CPMV) Nanoparticles with Antigen Presenting Cells In Vitro and In Vivo , 2009, PloS one.
[88] M. Finn,et al. Chemical modification of viruses and virus-like particles. , 2009, Current topics in microbiology and immunology.
[89] D. Pang,et al. Imaging viral behavior in Mammalian cells with self-assembled capsid-quantum-dot hybrid particles. , 2009, Small.
[90] Sonny C. Hsiao,et al. Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. , 2009, Journal of the American Chemical Society.
[91] M. Manchester,et al. Biomedical nanotechnology using virus-based nanoparticles. , 2009, Current topics in microbiology and immunology.
[92] Yun Jung Lee,et al. Fabricating Genetically Engineered High-Power Lithium-Ion Batteries Using Multiple Virus Genes , 2009, Science.
[93] M. Morris,et al. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.
[94] Inge J. Minten,et al. Controlled encapsulation of multiple proteins in virus capsids. , 2009, Journal of the American Chemical Society.
[95] Chuanbin Mao,et al. Self-assembly of drug-loaded liposomes on genetically engineered target-recognizing M13 phage: a novel nanocarrier for targeted drug delivery. , 2009, Small.
[96] M. Young,et al. Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties. , 2009, Nano letters.
[97] P. Nazarov,et al. Viruses: incredible nanomachines. New advances with filamentous phages , 2009, European Biophysics Journal.
[98] Qian Wang,et al. Viruses and virus-like protein assemblies—Chemically programmable nanoscale building blocks , 2009 .
[99] J. Fiedler,et al. Assembly of hybrid bacteriophage Qbeta virus-like particles. , 2009, Biochemistry.
[100] Gary Siuzdak,et al. Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface Vimentin , 2009, PLoS pathogens.
[101] Wei Wang,et al. Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[102] N. Steinmetz,et al. Buckyballs meet viral nanoparticles: candidates for biomedicine. , 2009, Journal of the American Chemical Society.
[103] S. Schmid,et al. Multivalent Display and Receptor‐Mediated Endocytosis of Transferrin on Virus‐Like Particles , 2010, Chembiochem : a European journal of chemical biology.
[104] Nicole F Steinmetz,et al. Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles , 2010, Nature Protocols.
[105] C. Mello,et al. Chemical modification of M13 bacteriophage and its application in cancer cell imaging. , 2010, Bioconjugate chemistry.
[106] M. Kinjo,et al. Low pH‐Triggered Model Drug Molecule Release from Virus‐Like Particles , 2010, Chembiochem : a European journal of chemical biology.
[107] Inge J. Minten,et al. Virus-like particles templated by DNA micelles: a general method for loading virus nanocarriers. , 2010, Journal of the American Chemical Society.
[108] N. Stephanopoulos,et al. Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells. , 2010, ACS nano.
[109] A. Heck,et al. Encapsulation of phthalocyanine supramolecular stacks into virus-like particles. , 2011, Journal of the American Chemical Society.
[110] M. McConnell,et al. Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions. , 2011, ACS nano.
[111] Allie C. Obermeyer,et al. Oxidative modification of native protein residues using cerium(IV) ammonium nitrate. , 2011, Journal of the American Chemical Society.
[112] Zhijun Zhang,et al. Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. , 2011, Bioconjugate chemistry.
[113] Allie C. Obermeyer,et al. Rapid chemoselective bioconjugation through oxidative coupling of anilines and aminophenols. , 2011, Journal of the American Chemical Society.